Targeted therapies in cancerology

CONTENTS
Targeted therapies in cancerology, focusing on the family of epidermal growth factor (EGF) receptors.
Evaluation of HER2 and REGF status by the pathologist.
Monoclonal antibodies and cancer therapy: from biotechnology to antibody-drugs.
Inhibitors of tyrosine kinase activity in EGF receptors: actions and molecules being developed.
Predictive factors in response to anti-REGF therapies.
Statistical methods for evaluating biological response modulators.
Targeted therapies linked with radiotherapy.
EGF receptors in ENT cancers: role and therapeutic implications.
EGF receptors in colorectal cancers: role and therapeutic implications.
EGF receptors in bronchopulmonary cancers: role and therapeutic implications.
Anti-HER2 and anti-EGFR. Clinical applications in breast cancerology.